SCM
Superstring Capital Management Portfolio holdings
AUM
$80.3M
This Quarter Return
+1.98%
1 Year Return
+68.23%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$83.8M
AUM Growth
+$83.8M
(-26%)
Cap. Flow
-$22.3M
Cap. Flow
% of AUM
-26.59%
Top 10 Holdings %
Top 10 Hldgs %
66.17%
Holding
52
New
13
Increased
7
Reduced
9
Closed
18
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$6.15M |
| 2 |
Pfizer
PFE
|
$4.97M |
| 3 |
Travere Therapeutics
TVTX
|
$4.26M |
| 4 |
Legend Biotech
LEGN
|
$3.08M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.39M |
Top Sells
| 1 |
NovoCure
NVCR
|
$8.55M |
| 2 |
Structure Therapeutics
GPCR
|
$5.88M |
| 3 |
IDEAYA Biosciences
IDYA
|
$5.84M |
| 4 |
Oric Pharmaceuticals
ORIC
|
$4.25M |
| 5 |
Zai Lab
ZLAB
|
$3.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cumberland Pharmaceuticals
CPIX
$54M
| – | – |
0
| – | – |
|
52
Dyne Therapeutics
DYN
$1.92B
| – | – |
-73,150
| Closed | -$1.72M |
|